Showing 3721-3740 of 8875 for: Cochrane Systematic Reviews Back
- Intensive versus conventional glycaemic control for treating diabetic foot ulcers
Cochrane Systematic Reviews, 13-Jan-2016
The estimated likelihood of lower limb amputation is 10 to 30 times higher amongst people with diabetes compared to those without diabetes. Of all non-traumatic amputations in people with diabetes, 85% are preceded by a foot ulcer. Foot ulceration associa
- Interactive computer-based interventions for sexual health promotion
Cochrane Systematic Reviews, 4-Aug-2010
Sexual health promotion is a major public health challenge; there is huge potential for health promotion via technology such as the Internet.
- Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people
Cochrane Systematic Reviews, 28-Jun-2012
The World Health Organization (WHO) estimates that the number of obese or overweight individuals worldwide will increase to 1.5 billion by 2015. Chronic diseases associated with overweight or obesity include diabetes, heart disease, hypertension and strok
- Interactive Health Communication Applications for people with chronic disease
Cochrane Systematic Reviews, 22-Oct-2008
Interactive Health Communication Applications (IHCAs) are computer-based, usually web-based, information packages for patients that combine health information with at least one of social support, decision support, or behaviour change support. These are in
- Interactive telemedicine: effects on professional practice and health care outcomes
Cochrane Systematic Reviews, 7-Sep-2015
Telemedicine (TM) is the use of telecommunication systems to deliver health care at a distance. It has the potential to improve patient health outcomes, access to health care and reduce healthcare costs. As TM applications continue to evolve it is importa
- Intercessory prayer for the alleviation of ill health
Cochrane Systematic Reviews, 15-Apr-2009
Prayer is amongst the oldest and most widespread interventions used with the intention of alleviating illness and promoting good health. Given the significance of this response to illness for a large proportion of the world's population, there has been co
- Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes
Cochrane Systematic Reviews, 24-Aug-2017
Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for mothers and their infants both perinatally and long term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention
- Interdental brushing for the prevention and control of periodontal diseases and dental caries in adults
Cochrane Systematic Reviews, 24-Apr-2019
Effective oral hygiene is a crucial factor in maintaining good oral health, which is associated with overall health and health-related quality of life. Dental floss has been used for many years in conjunction with toothbrushing for removing dental plaque
- Interferon after surgery for women with advanced (Stage II‐IV) epithelial ovarian cancer
Cochrane Systematic Reviews, 6-Jun-2013
Epithelial ovarian cancer (EOC) is a life-threatening disease. Most often women become symptomatic only in the advanced stages of the disease, increasing the difficulty of treatment. Whilst the disease responds well to surgery and chemotherapy, the relaps
- Interferon alpha for chronic hepatitis D
Cochrane Systematic Reviews, 1-Nov-2011
Hepatitis D virus is a small defective RNA virus that requires the presence of hepatitis B virus infection to infect a person. Hepatitis D is a difficult-to-treat infection. Several clinical trials have been published on the efficacy of interferon alpha f
- Interferon alpha for the adjuvant treatment of cutaneous melanoma
Cochrane Systematic Reviews, 12-Oct-2015
Interferon alpha is the only agent approved for the postoperative adjuvant treatment of high-risk cutaneous melanoma. However, the survival advantage associated with this treatment is unclear, especially in terms of overall survival. Thus, adjuvant interf
- Interferon Beta for Primary Progressive Multiple Sclerosis
Cochrane Systematic Reviews, 20-Jan-2010
This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006643. DOI: 10.1002/14651858.CD006643.pub2).
- Interferon beta for secondary progressive multiple sclerosis
Cochrane Systematic Reviews, 29-Nov-2011
Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase
- Interferon for acute hepatitis C
Cochrane Systematic Reviews, 23-Oct-2001
Acute hepatitis C virus (HCV) infection progresses to chronicity in the majority of patients. In order to prevent the progression to chronic disease, several studies have assessed interferon in patients with acute hepatitis C.
- Interferon for interferon naive patients with chronic hepatitis C
Cochrane Systematic Reviews, 22-Apr-2002
A previous meta-analysis of interferon therapy in naive patients with chronic hepatitis C has documented its efficacy in achieving virologic clearance, and improving liver biochemistry and histology; however, since its publication additional trials have b
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
Cochrane Systematic Reviews, 14-Dec-2012
The widely-accepted treatment outcome for chronic hepatitis C is the sustained viral response (that is, no measurable viral RNA in blood six months after treatment). However, this surrogate outcome (as well as the previously employed biochemical and histo
- Interferon in relapsing‐remitting multiple sclerosis
Cochrane Systematic Reviews, 23-Oct-2001
Recombinant interferons have been shown to suppress both the clinical and magnetic resonance imaging (MRI) measures of disease activity in patients with relapsing remitting multiple sclerosis (RRMS).
- Interferon‐alpha for maintenance of follicular lymphoma
Cochrane Systematic Reviews, 20-Jan-2010
Indolent non-Hodgkin's lymphoma, in particular follicular lymphoma (FL), is characterized by multiple remissions and relapses. Several studies have used interferon-alpha (IFN) to control this disease, both as induction and as maintenance therapy. It is no
- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
Cochrane Systematic Reviews, 24-Nov-2016
Interferons-beta (IFNs-beta) and glatiramer acetate (GA) were the first two disease-modifying therapies (DMTs) approved 20 years ago for the treatment of multiple sclerosis (MS). DMTs' prescription rates as first or switching therapies and their costs hav
- Interim PET‐results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta‐analysis of prognostic factor studies
Cochrane Systematic Reviews, 13-Jan-2020
Hodgkin lymphoma (HL) is one of the most common haematological malignancies in young adults and, with cure rates of 90%, has become curable for the majority of individuals. Positron emission tomography (PET) is an imaging tool used to monitor a tumour’s m
